IfosfamideMesnaAntineoplastic Agents, AlkylatingEtoposideSarcomaAntineoplastic Combined Chemotherapy ProtocolsCisplatinSoft Tissue NeoplasmsDoxorubicinCarboplatinDrug Administration ScheduleSalvage TherapyGerminomaSarcoma, EwingBone NeoplasmsCombined Modality TherapyCarbocysteineInfusions, IntravenousVincristineGranulocyte Colony-Stimulating FactorTesticular NeoplasmsPhosphoramide MustardsOsteosarcomaCyclophosphamideFanconi SyndromeNeuroectodermal Tumors, PrimitiveTreatment OutcomePaclitaxelBromisovalumProtective AgentsLung NeoplasmsDisease-Free SurvivalAcetaldehydeSurvival AnalysisSurvival RateNeoplasms, Germ Cell and EmbryonalCarcinoma, Small CellRemission InductionVinblastinePharmacists' AidesCarcinosarcomaDrug EvaluationMercaptoethanolCytochrome P-450 CYP2B1EpirubicinRhabdomyosarcomaHematologic DiseasesProdrugsDose-Response Relationship, DrugBleomycinMitomycinLeukopenia